ANI Pharma (ANIP) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
ANI Pharmaceuticals Reports First Quarter 2015 Financial Results
May 5, 2015 8:00 AM EDTBAUDETTE, Minn., May 5, 2015 /PRNewswire/ --Â ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three months ended March 31, 2015 and reaffirmed its revenue, non-GAAP EBITDA, and non-GAAP earnings per share guidance for 2015.
First Quarter 2015 Highlights Include:
First quarter net revenues of $18.8Â million, an increase of 72% as compared to $10.9 million for the same period in 2014. First quarter adjusted non-GAAP EBITDA of $11.5Â million, an increase of 170% as compared to $4.2 million for the same period in 2014. First quarter operating income of $9.6 million, an increase... More